EVIDENCE LIBRARY
Oral-Fluid Drug Concentrations Are Not a Stand-Alone Measure of Impairment
Oral fluid is convenient for roadside drug testing and can support evidence of recent exposure. It does not create a simple numerical bridge from saliva concentration to blood concentration or driving impairment.
Oral-fluid testing answers an important question: was a drug detectable in a specimen collected close to the event? It does not automatically answer a different question: was the person impaired?
That distinction is central to a 2018 review by Busardo and colleagues examining blood and oral-fluid drug concentrations in driving-under-the-influence-of-drugs investigations. The review recognized oral fluid as a practical matrix for roadside testing and recent-use detection. It also identified substantial obstacles to converting an oral-fluid concentration into a reliable estimate of blood concentration or cognitive impairment.
Presence, concentration, and effect are different propositions. A defensible interpretation keeps them separate.
Why oral fluid is attractive
Oral fluid can be collected under direct observation with less intrusion than blood collection. It may be obtained near the roadside and can reflect relatively recent exposure for many drugs. Those features make it useful for screening and for deciding whether additional investigation or confirmatory testing is warranted.
Compared with urine, oral fluid often has a closer temporal relationship to recent use. Urine commonly reflects excretion after use and may remain positive after the period of acute effect. Oral fluid can therefore fill a legitimate evidentiary role.
But convenience does not determine interpretive power. A specimen may be easy to collect and still be poorly suited to answering a concentration-effect question. See Oral Fluid Toxicology and Detection Windows in Toxicology.
Why the oral-fluid-to-blood ratio is unstable
Drugs do not move from blood into oral fluid according to one fixed ratio. The relationship depends on the compound's chemistry, including pKa, protein binding, lipophilicity, molecular size, and configuration. It can also be affected by oral-fluid pH, salivary flow, collection method, collection device, and the interval after use.
Busardo and colleagues reported significant variation both between different people and within the same person. That variability undermines any assumption that one oral-fluid number can be multiplied or divided by a universal factor to reconstruct blood concentration.
The direction of error may also change over time. Shortly after oral drug use, residual material in the mouth can elevate the oral-fluid concentration without a corresponding increase in blood. A later specimen may show a different relationship as contamination clears and the drug redistributes or is eliminated.
The result is a moving ratio, not a stable conversion constant.
Oral contamination matters
Oral contamination is especially important when a drug is smoked, swallowed, insufflated through the mouth or nose, or otherwise contacts the oral cavity. The collection device may capture drug left locally in the mouth in addition to drug transferred from the circulation.
That local contribution can make an early oral-fluid result look disproportionately high. The concentration may be genuine in the collected specimen, but its source and relationship to systemic effect remain disputed. A confirmed analytical result therefore does not by itself establish that the same concentration existed in blood or brain.
This is the same interpretive discipline applied elsewhere in forensic toxicology: the matrix matters. See Biological Matrices in Toxicology and Whole Blood and Plasma in Toxicology.
Screening is not impairment measurement
Related study and review aid: The THC oil and oral-fluid test guide examines device cutoffs, sensitivity, and the laboratory comparison in Suraev and colleagues’ 2024 study. This AI-assisted appraisal includes a records checklist and clearly labeled hypothetical arithmetic. It keeps the study results, illustrative calculations, and source-review limits separate.
A roadside oral-fluid device may be designed to classify a specimen as positive or negative near a cutoff. That is a screening function. Laboratory confirmation can establish that the target drug or metabolite was present in the submitted specimen. Neither step, standing alone, measures driving performance.
Impairment is a functional conclusion. It may require integration of driving behavior, timing, observations, medical conditions, tolerance, dose history, co-administered substances, and validated toxicological evidence. Even blood concentration is not a universal impairment meter for every psychoactive drug. Oral fluid adds another layer of biological and collection variability.
The 2018 review did not say that oral-fluid evidence is worthless. It said that the broader concentration-impairment relationship remains insufficiently defined and that variable oral-fluid-to-blood ratios make blood concentration estimates unreliable when derived from oral fluid alone.
Different drugs do not share one conversion rule
The matrix relationship is analyte-specific. THC can be affected by contamination of the mouth after smoking or oral use. Cocaine can become concentrated in oral fluid through ion trapping and can also be affected by local contamination. Several opioids and amphetamines have shown group-level relationships between oral-fluid and blood concentrations, but the reported ratios vary by drug, collection conditions, and time.
Heroin shows why the exact analyte matters. The short-lived metabolite 6-monoacetylmorphine can help distinguish heroin exposure from morphine or codeine use. Its detection window and stability differ from those of morphine. A conclusion about recent heroin exposure therefore depends on what compound was identified, not merely whether an opioid-class screen was positive.
A relationship reported for one drug, device, cutoff, or study population should not be imported into another case without validation.
What a careful case review should request
The reported number cannot be evaluated without knowing how it was produced. A technical review should obtain:
- The name and lot of the collection device
- The collection time and time of alleged driving
- The volume or adequacy indicator recorded during collection
- Device recovery and dilution information
- Screening cutoffs and confirmatory reporting limits
- The confirmation method and identification criteria
- Stability, transport, and storage records
- Information about the route and timing of alleged drug use
- Blood results, if collected, and whether blood and oral fluid were contemporaneous
- Validation data addressing the specific drug and device
These records help determine whether the result supports recent exposure, a reported specimen concentration, or a stronger conclusion. The laboratory report should not silently move among those propositions.
For the distinction between preliminary and definitive testing, see Confirmatory Drug Testing and Qualitative and Quantitative Toxicology.
The bottom line
Oral fluid can be useful evidence. Its best-supported role is often detection of recent drug exposure and efficient roadside screening. Its limitations become critical when someone tries to convert the result into a blood concentration or a conclusion about impairment.
The scientific problem is not whether the drug was detected. The problem is whether the reported oral-fluid concentration has a stable, validated relationship to the biological effect being claimed. Variable partitioning, oral contamination, collection effects, and timing can break that relationship.
A positive oral-fluid result should therefore be interpreted for what it measures. It should not be promoted into a stand-alone impairment test.
Source
Busardò FP, Pichini S, Pellegrini M, Montana A, Lo Faro AF, Zaami S, Graziano S. "Correlation between Blood and Oral Fluid Psychoactive Drug Concentrations and Cognitive Impairment in Driving under the Influence of Drugs." Current Neuropharmacology. 2018;16(1):84-96. PubMed record. PubMed Central full text. DOI: 10.2174/1570159X15666170828162057.
Editorial note: This article paraphrases the published review. Do not upload or reproduce the source PDF, its figures, tables, or publisher-formatted pages.